. 2021 Jan;9(4):442–451. doi: 10.52547/rbmb.9.4.442

Table 2.

The COX-2 mRNA expression and its association with different malignancy characterize.

Name of groups		No	Mean ± SD	Median	p-value
General	Case	45	1.088±0.878	1.466	<0.0001*
General	Control	45	-1.1e-10±0.67	-0.029	<0.0001*
Stages	Stage 0	3	0.274±0.1397	0.2461	0.192
	Stage I	7	1.148±0.8957	1.416
	Stage II	9	1.284±0.9771	1.531
	Stage III	11	1.203±0.6964	1.466
	Stage IV	3	1.783±0.2631	1.646
Grades	Low Grades	31	1.118±0.876	1.531	2
Grades	High Grades	13	0.9353±0.888	0.876	2
Vascular invasion	Positive	23	1.185±0.798	1.561	0.844
Vascular invasion	Negative	17	1.215±0.781	1.416	0.844
Lymphatic invasion	Positive (NOS)	21	1.365±0.693	1.581	0.117
	Positive (Extensive)	9	0.811±0.747	0.4261
	Negative	8	1.242±0.844	1.434
Perineural invasion	Positive	6	1.54±0.98	0.46	0.086
Perineural invasion	Negative	34	1.043±0.84	0.27	0.086
Extracapsular node extension	Positive	4	1.63±0.736	1.85	0.13
Extracapsular node extension	Negative	35	1.079±0.824	1.40	0.13
Statue of patients	Alive	34	1.087±0.84	1.434	0.170
Statue of patients	Deceased	9	1.508±0.499	1.581	0.170